Recently, the first-ever endovascular aneurysm repair (EVAR) procedure was performed at ProMedica Defiance Regional Hospital by Brett Aplin, MD, a vascular surgeon at ProMedica Physicians Jobst ...
How do the results of endovascular repair of abdominal aortic aneurysm (AAA) compare with those after an open surgical procedure? To answer this question, the investigators conducted a randomized ...
Over more than four decades, Cook Medical has pioneered numerous innovations aimed at reducing patient risk and improving the quality of care physicians can provide. An example is the Zenith AAA ...
That women fare worse than men after treatment for abdominal aortic aneurysm isn’t news, but 10 years’ worth of US registry data show that the difference is long-lasting and appears restricted to ...
How do the long-term results of endovascular repair of aortic aneurysms compare with open surgical procedures? The study authors conducted a randomized trial in 37 UK hospitals. A total of 1252 ...
WINSTON-SALEM, N.C. - May 30, 2019 - A minimally invasive procedure to repair abdominal aneurysms thought to be less effective than traditional open surgery has been shown to perform as well as the ...
IRVINE, Calif., Lombard Medical, Inc., a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that it has received CE Mark ...
The EVAR procedure, which can be performed under local anaesthetic, is the most common option. The technique involves inserting a tiny flexible plastic tube, called an EVAR device, inside the bulge to ...
A minimally invasive procedure to repair abdominal aneurysms thought to be less effective than traditional open surgery has been shown to perform as well as the open repair and be as long-lasting.
Please provide your email address to receive an email when new articles are posted on . The FDA has issued a letter to health care providers emphasizing the importance of annual follow-up in patients ...
Endologix Inc. is on a path to expanding its Ovation platform through its ELEVATE IDE clinical study. The Irvine, Calif.-based company said the 75-patient trial will evaluate the safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results